{"product_id":"global-dual-energy-x-ray-absorptiometry-market-size-study-forecast-by-application-osteoporosis-osteopenia-others-by-end-use-hospitals-imaging-centres-others-and-regional-analysis-2022-2029","title":"Global Dual Energy X-ray Absorptiometry Market Size study \u0026 Forecast, by Application (Osteoporosis, Osteopenia, Others), By End-Use (Hospitals, Imaging Centres, Others) and Regional Analysis, 2022-2029","description":"\u003cp\u003eGlobal Dual Energy X-ray Absorptiometry Market Size study \u0026amp; Forecast, by Application (Osteoporosis, Osteopenia, Others), By End-Use (Hospitals, Imaging Centres, Others) and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal Dual Energy X-ray Absorptiometry Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Dual-energy X-ray absorptiometry (DEXA) is a medical imaging technique used to assess the bone mineral density and detect osteoporosis. This process is also known as densitometry. DEXA is a more reliable approach that uses two energies to obtain precise results independent of the thickness and composition of the soft tissue, exposing users to less radiation. The increasing adoption of DEXA as a diagnostic tool for osteoporosis, increasing demand for early diagnosis and treatment of bone diseases, as well as the increasing number of chronic diseases in the mass, are primarily driving the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eAccording to IOF research, the amount of individuals in Asia with osteoporosis and osteopenia is anticipated to climb to 286.6 million by 2020 and 533.3 million by 2050. Hip fractures have already increased two- to thrice in most Asian nations during the previous 30 years. Similarly, according to WHO, non-communicable diseases and chronic diseases account for around 41 Million deaths globally equivalent to 74%, thus, in turn, these factors are expected to escalate the demand for DEXA devices in the global market. Furthermore, increasing osteoporosis incidences in the ageing population and development of DEXA devices are providing tremendous potential for market expansion in the following years. However, complexity in the operation of DEXA devices is restricting the market growth over the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Dual Energy X-ray Absorptiometry Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World.  The North America dominated the market in terms of revenue due to various regional organizations' combined efforts to increase their R\u0026amp;D skills and maintain good medical standards. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as rising expenditure on healthcare infrastructure and growing awareness about the benefits of dual emission x-ray absorptiometry (DEXA) equipment are burgeoning the market growth in the forecasting years.\u003c\/p\u003e \n\n\u003cp\u003eMajor market players included in this report are:\u003cbr\u003e\nGE HealthCare Technologies Inc.\u003cbr\u003e\nHologic, Inc.\u003cbr\u003e\nMedilink International\u003cbr\u003e\nSwissray Medical AG\u003cbr\u003e\nFonar Corporation\u003cbr\u003e\nOsteometer Meditech Inc.\u003cbr\u003e\nFuruno Electric Co., Ltd. \u003cbr\u003e\nBeamMed Ltd.\u003cbr\u003e\nScanflex Healthcare AB\u003cbr\u003e\nMedonica Co., Ltd.\u003cbr\u003e\nRecent Developments in the Market:\u003cbr\u003e\nIn April 2022, the installation of the Horizon DXA bone densitometry equipment from Hologic Inc. has allowed Newman Regional Health to increase the range of health and wellness services it offers to both men and women.\u003cbr\u003e\nIn March 2022, Aurora Spine Corporation executed one of the first DEXA-C implantations in history, where the implant density perfectly matched the patient's bone quality at Cypress Pointe Surgical Hospital in Louisiana.\u003cbr\u003e\nGlobal Dual Energy X-ray Absorptiometry Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Application, End-Use, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e \n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e \n\n\u003cp\u003eBy Application:\u003cbr\u003e\nOsteoporosis\u003cbr\u003e\nOsteopenia\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End-Use:\u003cbr\u003e\nHospitals\u003cbr\u003e\nImaging Centres\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia \u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nROLA\u003cbr\u003e\nRest of the WorldCompanies Mentioned\u003cbr\u003e\nGE HealthCare Technologies Inc.\u003cbr\u003e\nHologic, Inc.\u003cbr\u003e\nMedilink International\u003cbr\u003e\nSwissray Medical AG\u003cbr\u003e\nFonar Corporation\u003cbr\u003e\nOsteometer Meditech Inc.\u003cbr\u003e\nFuruno Electric Co., Ltd. \u003cbr\u003e\nBeamMed Ltd.\u003cbr\u003e\nScanflex Healthcare AB\u003cbr\u003e\nMedonica Co., Ltd.\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 200 Pages \/ MCW16236079","offer_id":47651432464690,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-dual-energy-x-ray-absorptiometry-market-size-study-forecast-by-application-osteoporosis-osteopenia-others-by-end-use-hospitals-imaging-centres-others-and-regional-analysis-2022-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}